462 - First-in-Human study of [18F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867) - Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting

462 - First-in-Human study of [¹⁸F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867)

Neurosciences -> Neurology and Psychiatry 462

462 - First-in-Human study of [¹⁸F]SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals (ID 867)

Session Name

Novel Neuroimaging Approaches

Speakers

Z. Cai

Authors

Presentation Topic

Neurosciences -> Neurology and Psychiatry

Presentation Number

462

Previous Eposter

458 - Preliminary Evidence for [¹¹C]PBR28 Sensitivity to Alcohol Challenge in Human Brain (ID 865)

Next Eposters

464 - Validation of multidose vial preparation fill line within F-18 Fludeoxyglucose manufacturing. (ID 338)

465 - Optimization of [⁶⁸Ga] Production via Cyclotron Irradiation 1.0 M Zn(NO₃)₂ solution for the Synthesis of [Ga-68] PSMA-11 HBED. (ID 344)

466 - Validating Cyclotron-Produced ⁶⁸Ga as an Alternative Source for Compounding Radiopharmaceutical Kits (ID 337)

468 - Production of [⁸⁹Zr]Oxinate₄and cell labelingfor human use (ID 343)

469 - Improved synthesis of [¹⁸F]fluoro-d₂-methyl tosylate suitable for automated pharmaceutical labeling (ID 342)

470 - Radiosynthesis of [¹⁸F]-flumazenil and its clinical utilization. (ID 341)

471 - Synthesis and preclinical evaluation of a molecular probe for imaging lung cancer with L858R/T790M mutation of epidermal growth factor receptor (EGFR) (ID 340)

472 - Histopathologic correlation with ⁶⁸Ga PSMA PET/CT in Non Prostate Tumors. (ID 522)

473 - Clinical Application of SPECT-CT Imaging with 99mTc/PSMA T4 in patients with Recurrent Prostate Cancer (ID 523)

474 - A Pilot Study on 68Ga-PSMA-11 PET/CT in Assessing Metastatic Clear Cell Renal Cell Carcinoma (ID 521)